Dedicated to the memory of Professor Maria N Preobrazhenskaya ✠ Bis-alkylthio maleimido derivatives have been prepared from teicoplanin pseudoaglycon by reaction of its primary amino group with N-ethoxycarbonyl bis-alkylthiomaleimides. Some of the new derivatives displayed excellent antibacterial activity against resistant bacteria.
INTRODUCTION
Glycopeptide antibiotics exert their antibacterial activity by inhibiting two sequential enzymatic reactions-transglycosylation and transpeptidation-in the bacterial cell-wall biosynthesis. The antibiotics recognize and tightly bind to the L-Lys-D-Ala-D-Ala termini of peptidoglycan precursors at the external side of the developing bacterial membrane. In this way transglycosylation and transpeptidation are physically prevented, arresting cell-wall elongation and crosslinking and leading to cell lysis. 1 Due to the lack of cross-resistance to other antibacterial drugs, the glycopeptide antibiotics have become first-line drugs for the treatment of life-threatening multi-drug resistant infections by Gram-positive bacteria. 2 The emergence and spread of glycopeptide-resistant enterococci and glycopeptide intermediate-resistant Staphylococcus aureus, as well as teicoplanin-resistant Staphylococcus haemolyticus 3 present a serious global challenge and have led to renewed interest in the development of novel, effective and safe antibacterials including new derivatives of glycopeptide antibiotics. [4] [5] [6] Inspired by the high activity of the semisynthetic lipoglycopeptide antibiotics telavancin, 7 dalbavancin 8 and oritavancin 9 against vancomycin-resistant bacteria, we have started a program to produce new antibiotics by introducing lipophilic subtituents to the primary amino function of ristocetin aglycon and of teicoplanin pseudoaglycon. Applying various approaches including squaric acid conjugation method, azide-alkyne cycloaddition reaction or three-component isoindole formation, we have prepared a large set of new derivatives exhibiting high antibacterial [10] [11] [12] [13] and, in some cases, robust antiinfluenza virus activity. [14] [15] [16] [17] Recently, Caddick, Baker and coworkers [18] [19] [20] [21] reported on applications of 3,4-dibromomaleimides for site-specific protein modification and bioconjugation. The method is based on addition-elimination reaction of thiols to the bromomaleimides leading to regeneration of the double bond resulting in thiomaleimide products (Scheme 1). Last year the group of Caddick and Baker published a simple method for the synthesis of N-functionalised bromo-and thiomaleimides through the corresponding N-ethoxycarbonyl maleimide derivatives. 22 Applying these recent results of maleimide chemistry we describe here derivatisation of teicoplanin pseudoaglycon with thiomaleimide substituents carrying two lipophilic alkyl or aryl sulfide side chains.
RESULTS AND DISCUSSION
Dibromomaleimide (1) that can be obtained by simple bromination of maleimide 23 has been allowed to react with a range of thiols including the 6-thio-D-galactose derivative 2a, thiophenol 2b, phenylmethanethiol 2c, dodecanethiol 2d, octanethiol 2e, propanethiol 2f and t-butyl mercaptane 2h, representing a series of substituents of different lipophilicity.
The obtained sulfides 3a-g have been then ethoxycarbonylated with ethyl chloroformate in the presence of potassium carbonate to provide 5a-g, ready for a reaction with a primary amino group (Scheme 2). Direct methoxycarbonylation 22 of dibromomaleimide offers an alternative route for the synthesis of the targeted N-functionalized dithiomaleimide as it is illustrated by the synthesis of 6g. We tested this route with several thiols such as 2d-2g, however, the sulfide formation showed low efficacy in all cases.
Next, teicoplanin pseudoaglycon 7 16 has been reacted with N-ethoxycarbonyl maleimides 5a-g and 6g in the presence of triethylamine (Table 1 ). In these reactions bis-alkyl-or arylthiomaleimide 8a-f were formed in moderate yields, together with the Nalkoxycarbonyl derivatives of the teicoplanin pseudoaglycon (9 and 10). The formation of 9 and 10 can be explained by the steric hindrance of the amino function of 7. In the case of 5g and 6g, the undesired carbamate derivatives 9 and 10 were dominantly formed, probably due to the presence of bulky t-butyl substituents of the reagents.
Antibacterial activity of maleimido-teicoplanin-pseudoaglycons was evaluated on a panel of Gram-positive bacteria ( Table 2 ). The Dgalactose-containing 8a, the bis-phenylthio derivative 8b and the bisbenzylthio derivative 8c displayed similar activities than teicoplanin pseudoaglycon 7 with one exception: the maleimido compounds 8a-c were active against Enterococcus faecalis 15 376 having vanA resistance gene while teicoplanin and 7 were completely inactive against this bacterium strain.
The detected antibacterial activities of 8d, 8e and 8f were related to the length of the alkyl chain substituents of their maleimide residues. The bis-dodecyl derivative 8d was inactive, the bis-octyl derivative 8e was a weak antibacterial and the bis-propylthio compound 8f displayed very high activity. It can be supposed that a correlation exists between lipophilicity of the maleimide substituents and antibacterial activity, and the high lipophilicity erodes the activity. To test this hypothesis, logP (logarithm of partition coefficient between noctanol and water) values were calculated for N-methyl maleimide derivatives 11a-f and the calculated logP values corroborate our postulation ( Table 3 ).
In conclusion we have utilized, for the first time, bis-sulfide derivatives of N-alkoxycarbonyl maleimide for versatile derivatisation of teicoplanin pseudoaglycon. It turned out that lipophilicity of substituents of the maleimide ring has strong influence on the antibacterial activity of these derivatives. Further synthetic tuning of these chemical structures hopefully will result in even more effective antibacterials.
EXPERIMENTAL PROCEDURE General information
Maleimide and thiols 2b-2g were purchased from Sigma-Aldrich Chemical (St Louis, MO, USA). 2,3-Dibromomaleimide 1, 1,2:3,4-di-O-isopropylidene-6deoxy-6-thio-α-D-galactopyranose 2a and teicoplanin pseudoaglycon 7 were prepared according to literature procedures. TLC analysis was performed on Kieselgel 60 F 254 (Merck, Darmstadt, Germany) silica gel plates with visualization by immersing in ammonium-molibdate solution followed by heating or Pauly-reagent in the case of teicoplanin derivatives. Column chromatography was performed on silica gel 60 (Merck 0.063-0.200 mm), flash column chromatography was performed on silica gel 60 (Merck 0.040-0 0.063 mm). Organic solutions were dried over MgSO 4 and concentrated under vacuum. The 1 H (400 and 500 MHz) and 13 
General method A for preparation maleimide bis-sulfides (3a-3g)
To a stirred solution of 2,3-dibromomaleimide 23 (1.0 mmol) in CH 2 Cl 2 (20 ml) Et 3 N (2.0 mmol) and thiol (2.1 mmol) were added under argon atmosphere and stirred for 3 h at room temperature. The reaction mixture was evaporated, and the crude product was purified by flash chromatography to give the desired compound.
General method B for preparation N-ethoxycarbonyl maleimide bis-sulfides (5a-5g)
To a stirred solution of maleimide bis-sulfide (1.0 mmol) in dry acetone (20 ml) K 2 CO 3 (1.2 mmol) and ethyl chloroformate (1.2 mmol) were added under argon atmosphere and stirred for 3 h at room temperature. The reaction mixture was diluted with CH 2 Cl 2 , filtered through a pad of Celite and evaporated. The crude product was used for further step without purification.
General method C for the synthesis of teicoplanin pseudoaglycon derivatives (8a-8f)
To a stirred solution of teicoplanin pseudoaglycon 16 Compound 6g. To a stirred solution of 2,3-dibromomaleimide (0.255 g, 1.0 mmol) in tetrahydrofuran (4 ml) N-methylmorpholine (76 μl, 1.1 mmol) and methyl chloroformate (85 μl, 1.1 mmol) were added at 0°C. When TLC (nhexane:acetone = 8:2) showed complete conversion of the starting material (3 h), the reaction mixture was diluted with CH 2 Cl 2 , filtered through a pad of Celite and evaporated. The obtained crude 4 (0.308 g) was reacted, without purification, with t-butyl mercaptan 2g (237 μl, 2.1 mmol) according to general method A to give compound 6g (0.150 g). The crude product was used for further step without purification.
Compound 8a. Teicoplanin pseudoaglycon (140 mg, 0.1 mmol) was reacted with compound 5a (100 mg, 0.14 mmol) according to general method C. The crude product was purified by silica gel chromatography in toluene:methanol = 
NMR analysis
The 1 H and 13 C NMR data of the teicoplanin derivatives 8a-f, 9 and 10 are collected in Tables 4 and 5 . The spectra were recorded at 500.13/125.76 MHz frequencies, respectively, at 300 K, using DMSO-d 6 , as solvent. Numbering atoms in teicoplanin derivatives are given in Figure 1 . Signal assignments were aided by 2D HSQC, TOCSY (15 and 60 ms mixing times) and HMBC (60 ms mixing time) experiments.
